WASHINGTON, July 26, 2010 – To plug it in and keep it beating, these two agencies must keep on meeting was the general theme of a panel discussion Monday convened by the Federal Communications Commission and Food and Drug Administration to address the current state of wireless health, and the lessons learned in those fields.
The FCC is responsible for overseeing the efficient use of airwaves, and the FDA is responsible for the safety and efficacy of medical devices. The FCC said the meeting was held in part to move forward on recommendations made in the FCC's National Broadband Plan that was released in March.
“I think that the world is moving way faster than many of our folks are aware of,” said panelist Bernie Liebler of AdvaMed, an association of advanced medical technology providers. “We need both agencies to pay a lot of attention.”
Panelists commented on the evolution of the regulation of the telephone system and agreed that lessons could be learned when considering regulation of this facet of the healthcare industry.
Charles Farlow of medical device manufacturer Medtronic gave the example of his company’s Telemetry System that more than 500,000 patients have registered to use.
Farlow said regulators must keep in mind that when a patient has a medical device implanted in the body - like those patients using the Medtronic network - they may have it for decades, and the spectrum the devices use must be there for the duration of their operability.
Panelists agreed that regulation was important for safety, but that it should not stifle innovation in this exciting new field.
Elliot Sloane, a professor at Drexel University’s School of Biomedical Engineering, said the current CIA model – Confidentiality, Integrity and Availability – for healthcare must also have an “S” for safety.
Sloane suggested creating federally funded testing facilities, like the one he is starting at Drexel, for new devices created for the industry.
Safety wasn’t the only issue though. Many panelists reiterated the importance of consistency, not only between agencies, but over time.
Bonnie Norman of Intel urged regulators to not get lost in the technology itself, but look at its purpose and the problem it is trying to solve.
Norman said technologies must be safe so that a patient does not have to wonder, for example, whether or not their device’s urgent text message seeking help was received by a care provider.
The balance between innovation and safety was at the crux of every argument.
- U.S. Progress on AI and Quantum Computing Will Best China, Says CTO Michael Kratsios
- Poor Broadband Maps and Lack of a Consolidated Voice Hinder Advocacy for Better Rural Internet
- NTIA Broadband Webinar With Pew, Georgia and Tennessee Officials Discuss Solutions to Digital Divides
- Broadband Roundup: Zuckerberg and EU Discuss Rules for Facebook, Trumps Supports Oracle, Nevada Caucus Anxieties
- Criminal Justice Reform Advocates Agree that Current AI Assessment Tools are Garbage, But Differ on How to Proceed
Signup for Broadband Breakfast
Broadband Data9 months ago
Pennsylvania Broadband Speeds Worse Than Previously Believed, According to State Report
Intellectual Property7 months ago
In Congressional Oversight Hearing, Register of Copyrights Says Office Is Responding to Online Users
Broadband Data8 months ago
California Report: Income Most Significant Factor in Low Broadband Adoption
FCC10 years ago
Telecom Companies Are Using Fight Interrupting Oscar Ceremony Broadcast To Manipulate Public and FCC, Argue Broadcasters
Broadband Roundup6 months ago
Cable Industry Touts Energy Efficiency, Next Century Highlights Open Access Fiber, Aspen Forum Set
Privacy and Security6 months ago
Comparing Privacy Policies for Wearable Fitness Trackers: Apple, Fitbit, Xiaomi and Under Armour
Open Access2 months ago
UTOPIA Fiber: A Model Open-Access Network
Antitrust5 months ago
Addressing the Impact of Big Data Upon Antitrust is More Complicated Than a Big Tech Breakup